Dihydromyricetin alleviates doxorubicin-induced cardiotoxicity by inhibiting NLRP3 inflammasome through activation of SIRT1
Zhenzhu Sun, Wenqiang Lu, Na Lin, Hui Lin, Jie Zhang, Tingjuan Ni, Liping Meng, Chuanjing Zhang, Hangyuan Guo
Topics & Concepts
CardiotoxicityInflammasomePharmacologyDoxorubicinAnthracyclineIn vivoChemistryDownregulation and upregulationInflammationMedicineReceptorBiologyToxicityBiochemistryImmunologyChemotherapyInternal medicineCancerOrganic chemistryBiotechnologyBreast cancerGeneMedicinal plant effects and applicationsBiological Activity of Diterpenoids and BiflavonoidsPomegranate: compositions and health benefits